|
|
|
|
LEADER |
00972 am a22002173u 4500 |
001 |
84601 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Kleinke, Andrew S.
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Chemistry
|e contributor
|
100 |
1 |
0 |
|a Jamison, Timothy F.
|e contributor
|
100 |
1 |
0 |
|a Kleinke, Andrew S.
|e contributor
|
100 |
1 |
0 |
|a Jamison, Timothy F.
|e contributor
|
700 |
1 |
0 |
|a Jamison, Timothy F.
|e author
|
245 |
0 |
0 |
|a Hydrogen-Free Alkene Reduction in Continuous Flow
|
260 |
|
|
|b American Chemical Society (ACS),
|c 2014-01-27T19:46:11Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/84601
|
520 |
|
|
|a The first continuous hydrogenation that requires neither H[subscript 2] nor metal catalysis generates diimide by a novel reagent combination. The simple flow reactor employed minimizes residence time by enabling safe operation at elevated temperature.
|
520 |
|
|
|a Novartis (Firm)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Organic Letters
|